| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |